Cipher Pharmaceuticals
Cipher Pharmaceuticals is a specialty pharmaceutical company that develops and acquires innovative skin care solutions to address unmet medical needs. The company offers a range of prescription dermatology products, including Bionect for managing various skin injuries and Nuvail for nail dystrophy. Additionally, it provides consumer skin care products such as AL12, Inova, Pro: 12 Mousse, and Umecta, which target moisture retention and skin repair. Cipher also markets prescription medications like Absorica for severe acne and ConZip for chronic pain management. The company focuses on enhancing existing drug formulations through novel delivery technologies and actively seeks to in-license products to expand its portfolio. Cipher Pharmaceuticals operates primarily in Canada and the United States and has been part of EPI Health, LLC since 2017.
Cardiome Pharma Corp. is a specialty biopharmaceutical company dedicated to the discovery, development and commercialization of new therapies that will improve the health of patients suffering from heart disease around the world. Cardiome has one marketed product, BRINAVESSTM (vernakalant IV), approved in Europe and other territories for the rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults.
INNOCUTIS is a pharmaceutical and medical device company specializing in the development and commercialization of therapies and devices focused on medical treatment of dermatological conditions. INNOCUTIS’ current portfolio of products consist of established branded prescriptions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.